Tango Therapeutics (TNGX) SEC Filings & 10K Form

$7.44
+0.11 (+1.50%)
(As of 04/26/2024 ET)

Recent Tango Therapeutics SEC Filings

DateFilerForm TypeView
04/17/2024
3:53 PM
Tango Therapeutics (Filer)
Form PRE 14A
04/08/2024
7:46 AM
Southpoint Capital Advisors LP (Filed by)
Tango Therapeutics (Subject)
Form SC 13G/A
03/18/2024
7:27 AM
Tango Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/18/2024
6:19 AM
Tango Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2024
6:08 AM
Tango Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
4:52 PM
Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
11:32 AM
Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2024
8:49 AM
FMR LLC (Filed by)
Tango Therapeutics (Subject)
Form SC 13G/A
02/08/2024
8:04 PM
Crystal Adam (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
8:08 PM
Beckman Daniella (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
8:09 PM
Barry Douglas (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
8:14 PM
Tango Therapeutics (Issuer)
Weber Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
6:00 AM
Tango Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2023
6:29 AM
Tango Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2023
6:07 AM
Tango Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
3:49 PM
Crystal Adam (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2023
4:23 PM
BCTG Holdings, LLC (Filed by)
Tango Therapeutics (Subject)
Form SC 13D/A
10/17/2023
6:41 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
Form 4/A
10/17/2023
5:04 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
2:33 PM
EcoR1 Capital, LLC (Filed by)
Tango Therapeutics (Subject)
Form SC 13G/A
10/16/2023
2:42 PM
EcoR1 Capital, LLC (Reporting)
Tango Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/11/2023
8:22 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2023
6:22 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
Form 4/A
10/10/2023
8:42 PM
MVA Investors, LLC (Reporting)
Tango Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/10/2023
8:43 PM
Boxer Capital, LLC (Reporting)
Tango Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/21/2023
4:16 PM
EcoR1 Capital, LLC (Filed by)
Tango Therapeutics (Subject)
Form SC 13G
09/11/2023
11:15 PM
Tango Therapeutics (Filer)
Form EFFECT
09/11/2023
7:23 AM
FMR LLC (Filed by)
Tango Therapeutics (Subject)
Form SC 13G/A
09/01/2023
6:34 AM
Tango Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/30/2023
5:04 AM
Tango Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/24/2023
3:10 PM
Tango Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
08/22/2023
3:15 PM
Tango Therapeutics (Issuer)
Third Rock Ventures GP VI, L.P. (Reporting)
Third Rock Ventures VI, L.P. (Reporting)
TRV GP VI, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/21/2023
3:16 PM
Nextech Crossover I GP S.a r.l. (Filed by)
Tango Therapeutics (Subject)
Form SC 13G
08/16/2023
3:40 PM
BCTG Holdings, LLC (Filed by)
Tango Therapeutics (Subject)
Form SC 13D/A
08/15/2023
8:34 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2023
6:24 AM
Tango Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2023
6:57 AM
Tango Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2023
6:25 AM
Tango Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2023
8:36 PM
Borisy Alexis (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
8:39 PM
Calhoun Lesley Ann (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
8:40 PM
Rothenberg Mace (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Biden replacement revealed? (Ad)

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

See his shocking evidence in this new report
06/08/2023
8:32 PM
Davis Aaron I. (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
8:33 PM
Peters Malte (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
8:34 PM
Huber Reid M (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
3:49 PM
Tango Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2023
6:31 AM
Tango Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2023
6:22 AM
Tango Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:TNGX) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners